Exploration of clinical and ethical issues in an expanded newborn metabolic screening programme: a qualitative interview study of healthcare professionals in Hong Kong
Hong Kong Medical Journal · 2024
DOI: 10.12809/hkmj2210234 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Hong Kong Medical Journal, 2024. Verfasst von O M Y Ngan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Ethics and Humanities Unit, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Neonatal Screening, Metabolism, Inborn Errors, Qualitative Research, Health Personnel. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
INTRODUCTION: The Newborn Screening Programme for Inborn Errors of Metabolism (NBSIEM) enables early intervention and prevents premature mortality. Residual dried bloodspots (rDBS) from the heel prick test are a valuable resource for research. However, there is minimal data regarding how stakeholders in Hong Kong view the retention and secondary use of rDBS. This study aimed to explore views of the NBSIEM and the factors associated with retention and secondary use of rDBS among healthcare professionals in Hong Kong. METHODS: Between August 2021 and January 2022, semi-structured interviews were conducted with 30 healthcare professionals in obstetrics, paediatrics, and chemical pathology. Key themes were identified through thematic analysis, including views towards the current NBSIEM and the retention and secondary use of rDBS. RESULTS: After implementation of the NBSIEM, participants observed fewer patients with acute decompensation due to undiagnosed inborn errors of metabolism. The most frequently cited clinical utilities were early detection and improved health outcomes. Barriers to rDBS storage and its secondary use included uncertain value and benefits, trust concerns, and consent issues. CONCLUSION: This study highlighted healthcare professionals' concerns about the NBSIEM and uncertainties regarding the handling or utilisation of rDBS. Policymakers should consider these concerns when establishing new guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Ethics and Humanities Unit, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
- Centre for Medical Ethics and Law, The University of Hong Kong, Hong Kong SAR, China.
- Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Hong Kong Hub of Paediatric Excellence, The Chinese University of Hong Kong, Hong Kong SAR, China.
Zitieren
APA
Ngan, O. M. Y., Tam, C. J., & Li, C. K. (2024). Exploration of clinical and ethical issues in an expanded newborn metabolic screening programme: a qualitative interview study of healthcare professionals in Hong Kong. Hong Kong Medical Journal. https://doi.org/10.12809/hkmj2210234
Vancouver
Ngan OMY, Tam CJ, Li CK. Exploration of clinical and ethical issues in an expanded newborn metabolic screening programme: a qualitative interview study of healthcare professionals in Hong Kong. Hong Kong Medical Journal. 2024. doi:10.12809/hkmj2210234
BibTeX
@article{Ngan2024,
author = {Ngan, O M Y and Tam, C J and Li, C K},
title = {Exploration of clinical and ethical issues in an expanded newborn metabolic screening programme: a qualitative interview study of healthcare professionals in Hong Kong},
journal = {Hong Kong Medical Journal},
year = {2024},
doi = {10.12809/hkmj2210234}
}
EUVIMED